| Takeda Pharma AG - VPRIV 200 U, Pulver zur Herstellung einer Infusionslösung |
| 61297 | | 01 | | VPRIV 200 U | | Pulver zur Herstellung einer Infusionslösung | | A16AB10 | | Velaglucerase Alfa | | 29.08.2011 | | |
|
| Composition |
| Praeparatio cryodesiccata: velaglucerasum alfa 200 U., saccharum, natrii citras dihydricus, acidum citricum monohydricum, polysorbatum 20, pro vitro. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | Lyophilisate | | | | | | Active Agent | Dose |
|---|
| Velaglucerasum Alfa | 200 U |
| | | | Inactive agents |
|---|
| Citric Acid Monohydrate | | Natrii Citras Dihydricus | | Polysorbatum 20 | | Saccharum |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
